Cargando…

Plasma oxalic acid and cardiovascular risk in end-stage renal disease patients: a prospective, observational cohort pilot study

BACKGROUND/AIMS: It was hypothesized that oxalate might be strongly involved in atherogenesis and the inflammatory pathway that could result in an increased risk of cardiovascular disease (CVD) in end-stage renal disease (ESRD) patients. Therefore, this study aimed to address two primary research qu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stepanova, Natalia, Driianska, Victoria, Korol, Lesya, Snisar, Lyudmyla, Lebed, Larysa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Association of Internal Medicine 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8747923/ https://www.ncbi.nlm.nih.gov/pubmed/34167288 http://dx.doi.org/10.3904/kjim.2020.561

Ejemplares similares

Role of Impaired Oxalate Homeostasis in Cardiovascular Disease in Patients With End-Stage Renal Disease: An Opinion Article
por: Stepanova, Natalia
Publicado: (2021)

Impact of Regular or Extended Hemodialysis and Hemodialfiltration on Plasma Oxalate Concentrations in Patients With End-Stage Renal Disease
por: Ermer, Theresa, et al.
Publicado: (2017)

Oxalate Homeostasis in Non-Stone-Forming Chronic Kidney Disease: A Review of Key Findings and Perspectives
por: Stepanova, Natalia
Publicado: (2023)

Oxidative Stress in Peritoneal Dialysis Patients: Association with the Dialysis Adequacy and Technique Survival
por: Stepanova, Natalia, et al.
Publicado: (2019)

Plasma Endocan as a Predictor of Cardiovascular Event in Patients with End-Stage Renal Disease on Hemodialysis
por: Kim, Jin Sug, et al.
Publicado: (2020)

Plasma oxalate: comparison of methodologies
por: Stokes, Felicity, et al.
Publicado: (2020)

Idiopathic Oxalate Nephropathy Leading to End-Stage Kidney Disease: A Case Report
por: Saleem, Maryam, et al.
Publicado: (2023)

Baseline high-density lipoprotein level is associated with COVID-19 pneumonia severity in hemodialysis patients
por: Stepanova, N., et al.
Publicado: (2022)

Plasma Homocysteine Levels and Cardiovascular Events in Patients With End-Stage Renal Disease: A Systematic Review
por: ALSolami, Abdulilah A, et al.
Publicado: (2023)

Plasma Oxalate Concentration and Patients With CKD
por: Oka, Yoshinari, et al.
Publicado: (2021)

Cardiovascular Disease in Patients with End-Stage Renal Disease on Hemodialysis
por: Aoki, Jiro, et al.
Publicado: (2017)

Cardiovascular risk in children and adolescents with end stage renal disease
por: do Val, Maria Luiza, et al.
Publicado: (2019)

Assessment of Plasma Oxalate Concentration in Patients With CKD
por: Pfau, Anja, et al.
Publicado: (2020)

Plasma Leucine-Rich α-2-Glycoprotein 1 Predicts Cardiovascular Disease Risk in End-Stage Renal Disease
por: Yang, Feng-Jung, et al.
Publicado: (2020)

Diagnosis and Management of Cardiovascular Disease in Advanced and End‐Stage Renal Disease
por: Bhatti, Navdeep K., et al.
Publicado: (2016)

Circulating proteins as predictors of cardiovascular mortality in end-stage renal disease
por: Feldreich, Tobias, et al.
Publicado: (2018)

Inflammation and Cardiovascular Disease Associated With Hemodialysis for End-Stage Renal Disease
por: Wang, Yinghui, et al.
Publicado: (2022)

Contribution of Dietary Oxalate and Oxalate Precursors to Urinary Oxalate Excretion
por: Crivelli, Joseph J., et al.
Publicado: (2020)

Circadian rhythm of salivary cortisol, plasma cortisol, and plasma ACTH in end-stage renal disease
por: Raff, Hershel, et al.
Publicado: (2012)

POS-960 ASSOCIATION OF PARATHYROID HORMONE LEVEL WITH SEVERITY OF CORONAVIRUS-INDUCED PNEUMONIA IN HEMODIALYSIS PATIENTS
por: Rysyev, A., et al.
Publicado: (2022)

Association of Myeloperoxidase and the Atherogenic Index of Plasma in Children with End-Stage Renal Disease
por: Ristovski-Kornic, Danijela, et al.
Publicado: (2017)

Predictor of cardiovascular risks in end stage renal failure patients on maintenance dialysis
por: Lim, Christopher Thiam Seong, et al.
Publicado: (2015)

Effect of Hemodialysis on Plasma Glucose Profile and Plasma Level of Liraglutide in Patients with Type 2 Diabetes Mellitus and End-Stage Renal Disease: A Pilot Study
por: Osonoi, Takeshi, et al.
Publicado: (2014)

Renal oxalate stones in children with Zellweger spectrum disorders
por: Alhazmi, Hamdan Hammad
Publicado: (2018)

Cardiovascular Autonomic Neuropathy and its Association with Cardiovascular and All-cause Mortality in Patients with End-stage Renal Disease
por: Bokhari, Syed Rizwan A, et al.
Publicado: (2018)

NT-proBNP and stem cell factor plasma concentrations are independently associated with cardiovascular outcomes in end-stage renal disease hemodialysis patients
por: Rossignol, P, et al.
Publicado: (2022)

Inhibitors of Calcium Oxalate Crystallization for the Treatment of Oxalate Nephropathies
por: Kletzmayr, Anna, et al.
Publicado: (2020)

Primary Nonfunction of Renal Allograft Secondary to Acute Oxalate Nephropathy
por: Parasuraman, Ravi, et al.
Publicado: (2011)

Aggregation of Calcium Phosphate and Oxalate Phases in the Formation of Renal Stones
por: Xie, Baoquan, et al.
Publicado: (2014)

TRPV1 Hyperfunction Contributes to Renal Inflammation in Oxalate Nephropathy
por: Lu, Chien-Lin, et al.
Publicado: (2021)

Metabolomic changes in cats with renal disease and calcium oxalate uroliths
por: Jewell, Dennis E., et al.
Publicado: (2022)

Recombinant Lactobacillus plantarum expressing and secreting heterologous oxalate decarboxylase prevents renal calcium oxalate stone deposition in experimental rats
por: Sasikumar, Ponnusamy, et al.
Publicado: (2014)

Resveratrol Attenuates Oxalate-Induced Renal Oxidative Injury and Calcium Oxalate Crystal Deposition by Regulating TFEB-Induced Autophagy Pathway
por: Wu, Yue, et al.
Publicado: (2021)

End Stage Renal Disease and Medicare
por: Greer, Joel W.
Publicado: (2003)

Enrofloxacinium oxalate
por: Yamuna, Thammarse S., et al.
Publicado: (2014)

Oxalate Nephropathy
por: Etta, Praveen K., et al.
Publicado: (2023)

Plasma S100A12 Levels and Peripheral Arterial Disease in End-Stage Renal Disease
por: Shiotsu, Yayoi, et al.
Publicado: (2011)

Plasma porphyrins among end stage renal disease patients and cutaneous symptoms- is there still an association?
por: Goldman, Shira, et al.
Publicado: (2022)

Potential Cardiovascular Risk Protection of Bilirubin in End-Stage Renal Disease Patients under Hemodialysis
por: do Sameiro-Faria, Maria, et al.
Publicado: (2014)

Rationale and design for the Predictors of Arrhythmic and Cardiovascular Risk in End Stage Renal Disease (PACE) study
por: Parekh, Rulan S, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_7te7kgv2spl9k27pq79visulfe